nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk
|
Schonberg, Mara A. |
|
2016 |
160 |
3 |
p. 547-562 |
artikel |
2 |
Acknowledgement of reviewers 2015
|
|
|
2016 |
160 |
3 |
p. 575-579 |
artikel |
3 |
Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems
|
Choi, Misun |
|
2016 |
160 |
3 |
p. 475-489 |
artikel |
4 |
Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients
|
Maaren, M. C. van |
|
2016 |
160 |
3 |
p. 511-521 |
artikel |
5 |
Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade
|
Hennigs, A. |
|
2016 |
160 |
3 |
p. 491-499 |
artikel |
6 |
Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family
|
Yang, Ciyu |
|
2016 |
160 |
3 |
p. 447-456 |
artikel |
7 |
Circulating tumor cells in breast cancer: applications in personalized medicine
|
Lee, Jin Sun |
|
2016 |
160 |
3 |
p. 411-424 |
artikel |
8 |
Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race
|
Madubata, Chinwe C. |
|
2016 |
160 |
3 |
p. 563-572 |
artikel |
9 |
Erratum to: Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient
|
Churilla, Thomas M. |
|
2016 |
160 |
3 |
p. 573 |
artikel |
10 |
Internal mammary node adenopathy on breast MRI and PET/CT for initial staging in patients with operable breast cancer: prevalence and associated factors
|
Cheon, Hyejin |
|
2016 |
160 |
3 |
p. 523-530 |
artikel |
11 |
Investigation of breast cancer sub-populations in black and white women in South Africa
|
Dickens, Caroline |
|
2016 |
160 |
3 |
p. 531-537 |
artikel |
12 |
Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
|
Cazzaniga, M. E. |
|
2016 |
160 |
3 |
p. 501-509 |
artikel |
13 |
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
|
Lánczky, András |
|
2016 |
160 |
3 |
p. 439-446 |
artikel |
14 |
Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery
|
Brzezinska, Monika |
|
2016 |
160 |
3 |
p. 387-391 |
artikel |
15 |
Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trials
|
Petrelli, Fausto |
|
2016 |
160 |
3 |
p. 425-437 |
artikel |
16 |
Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care
|
Graffeo, Rossella |
|
2016 |
160 |
3 |
p. 393-410 |
artikel |
17 |
Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CAH1047R in HER2/ER-positive breast cancer
|
Cheng, Feixiong |
|
2016 |
160 |
3 |
p. 457-474 |
artikel |
18 |
Use of complementary and alternative medicine and breast cancer survival in the Health, Eating, Activity, and Lifestyle Study
|
Neuhouser, Marian L. |
|
2016 |
160 |
3 |
p. 539-546 |
artikel |